Press Releases

October 11, 2003 Lupin Q2 FY 2003-04 net profit before extraordinary items at Rs.518 mn,up 86%; sales up 36% at Rs 3609 mn

October 1, 2003 Lupin receives USFDA approval for ceftriaxone sterile vials for injection

September 25, 2003 Lupin receives USFDA approval for cefotaxime sterile vials for injection

August 25, 2003 Dr. Kamal K. Sharma to join Lupin as Managing Director

July 31, 2003 Lupin Q1 FY 2003-04 net profit up 38% at Rs 280.6 mn; sales up 23% at Rs 2,769 mn

July 28, 2003 Lupin receives USFDA approval for cefuroxime axetil tablets

May 20, 2003 Lupin FY2002-03 net sales up 19% at Rs 10.3 bn

April 17, 2003 Statement on media reports linking SARS outbreak with demand for Lupin’s ribavirin

February 24, 2003 Lupin receives USFDA approval for Cefixime Suspension